Acquisition of TCF3 and CCND3 Mutations and Transformation to Burkitt Lymphoma in a Case of B-Cell Prolymphocytic Leukemia

by Nguyen-Khac, Florence, Bouzy, Simon, Roos-Weil, Damien, Bravetti, Clotilde, Maillon, Agathe, Diop, M’boyba, Doualle, Cécile, Droin, Nathalie, Bernard, Olivier A., Chapiro, Elise
Published in Hemasphere (2021)

Serial transplantation unmasks galectin-9 contribution to tumor immune escape in the MB49 murine model

by Baloche, Valentin, Rivière, Julie, Tran, Thi Bao Tram, Gelin, Aurore, Bawa, Olivia, Signolle, Nicolas, Diop, M′Boyba Khadija, Dessen, Philippe, Beq, Stéphanie, David, Muriel, Busson, Pierre
Published in Sci Rep (2021)

Engraftment of chronic myelomonocytic leukemia cells in immunocompromised mice supports disease dependency on cytokines

by Zhang, Yanyan, He, Liang, Selimoglu-Buet, Dorothée, Jego, Chloe, Morabito, Margot, Willekens, Christophe, Diop, M'boyba Khadija, Gonin, Patrick, Lapierre, Valérie, Droin, Nathalie, Solary, Eric, Louache, Fawzia
Published in Blood Adv (2017)

Dynamic gene regulation by nuclear colony-stimulating factor 1 receptor in human monocytes and macrophages

by Bencheikh, Laura, Diop, M’Boyba Khadija, Rivière, Julie, Imanci, Aygun, Pierron, Gerard, Souquere, Sylvie, Naimo, Audrey, Morabito, Margot, Dussiot, Michaël, De Leeuw, Frédéric, Lobry, Camille, Solary, Eric, Droin, Nathalie
Published in Nat Commun (2019)

Acquired TET2 mutation in one patient with familial platelet disorder with predisposition to AML led to the development of pre‐leukaemic clone resulting in T2‐ALL and AML‐M0

by Manchev, Vladimir T., Bouzid, Hind, Antony‐Debré, Iléana, Leite, Betty, Meurice, Guillaume, Droin, Nathalie, Prebet, Thomas, Costello, Régis T., Vainchenker, William, Plo, Isabelle, Diop, M'boyba, Macintyre, Elizabeth, Asnafi, Vahid, Favier, Rémi, Baccini, Véronique, Raslova, Hana
Published in J Cell Mol Med (2016)

B-cell tumor development in Tet2-deficient mice

by Mouly, Enguerran, Ghamlouch, Hussein, Della-Valle, Veronique, Scourzic, Laurianne, Quivoron, Cyril, Roos-Weil, Damien, Pawlikowska, Patrycja, Saada, Véronique, Diop, M’Boyba K., Lopez, Cécile K., Fontenay, Michaela, Dessen, Philippe, Touw, Ivo P., Mercher, Thomas, Aoufouchi, Said, Bernard, Olivier A.
Published in Blood Adv (2018)

A miR-150/TET3 pathway regulates the generation of mouse and human non-classical monocyte subset

by Selimoglu-Buet, Dorothée, Rivière, Julie, Ghamlouch, Hussein, Bencheikh, Laura, Lacout, Catherine, Morabito, Margot, Diop, M’boyba, Meurice, Guillaume, Breckler, Marie, Chauveau, Aurélie, Debord, Camille, Debeurme, Franck, Itzykson, Raphael, Chapuis, Nicolas, Willekens, Christophe, Wagner-Ballon, Orianne, Bernard, Olivier A., Droin, Nathalie, Solary, Eric
Published in Nat Commun (2018)

DNMT3A(R882H) mutant and Tet2 inactivation cooperate in the deregulation of DNA methylation control to induce lymphoid malignancies in mice

by Scourzic, Laurianne, Couronné, Lucile, Pedersen, Marianne T., Della Valle, Véronique, Diop, M’boyba, Mylonas, Elena, Calvo, Julien, Mouly, Enguerran, Lopez, Cécile K., Martin, Nadine, Fontenay, Michaëla, Bender, Ambre, Guibert, Sylvain, Dubreuil, Patrice, Dessen, Philippe, Droin, Nathalie, Pflumio, Françoise, Weber, Michael, Gaulard, Philippe, Helin, Kristian, Mercher, Thomas, Bernard, Olivier A.
Published in Leukemia (2016)

Characterization of novel genomic alterations and therapeutic approaches using acute megakaryoblastic leukemia xenograft models

by Thiollier, Clarisse, Lopez, Cécile K., Gerby, Bastien, Ignacimouttou, Cathy, Poglio, Sandrine, Duffourd, Yannis, Guégan, Justine, Rivera-Munoz, Paola, Bluteau, Olivier, Mabialah, Vinciane, Diop, M’Boyba, Wen, Qiang, Petit, Arnaud, Bauchet, Anne-Laure, Reinhardt, Dirk, Bornhauser, Beat, Gautheret, Daniel, Lecluse, Yann, Landman-Parker, Judith, Radford, Isabelle, Vainchenker, William, Dastugue, Nicole, de Botton, Stéphane, Dessen, Philippe, Bourquin, Jean-Pierre, Crispino, John D., Ballerini, Paola, Bernard, Olivier A., Pflumio, Françoise, Mercher, Thomas
Published 2012

Constitutive activation of RAS/MAPK pathway cooperates with trisomy 21 and is therapeutically exploitable in Down syndrome B-cell Leukemia

by Laurent, Anouchka P., Siret, Aurélie, Ignacimouttou, Cathy, Panchal, Kunjal, Diop, M’Boyba K., Jenny, Silvia, Tsai, Yi-Chien, Ross-Weil, Damien, Aid, Zakia, Prade, Naïs, Lagarde, Stéphanie, Plassard, Damien, Pierron, Gaelle, Daudigeos-Dubus, Estelle, Lecluse, Yann, Droin, Nathalie, Bornhauser, Beat, Cheung, Laurence C., Crispino, John D., Gaudry, Muriel, Bernard, Olivier A., Macintyre, Elizabeth, Bonnigal, Carole Barin, Kotecha, Rishi S., Geoerger, Birgit, Ballerini, Paola, Bourquin, Jean-Pierre, Delabesse, Eric, Mercher, Thomas, Malinge, Sébastien
Published in Clin Cancer Res (2020)